Alzheimer's Research Corporation

Paterson, New Jersey 08759

0 studies enrolling now · 10 studies all time

What they study most

Aggression, Agitation, Alzheimer Dementia, Alzheimer Disease, Alzheimer's Disease, Dementia, Psychosis

Studies at this site

• Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION) — Completed
• A Study of Gantenerumab in Participants With Mild Alzheimer Disease — Completed
• AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext — Completed
• A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression — Stopped early
• Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients — Stopped early
• A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease — Stopped early
• Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44 — Completed
• Study of PRX-03140 Monotherapy in Subjects With Alzheimer's Disease — Stopped early
• A Study of PRX-03140 in Subjects With Alzheimer's Disease Receiving a Stable Dose of Donepezil — Stopped early
• Huperzine A in Alzheimer's Disease — Completed